Internal Medicine, Pulmonary Disease · Indianapolis, IN
NPI
1043486343
Since 2008
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
1402 E County Line Rd, Suite 2400
Indianapolis, IN, 46227
Phone (317) 887-7000
Groups this clinician bills Medicare through
Medicare paid, 2024
$100K
1,652 services
Medicare patients, 2024
770
Average age 71
Drug cost, 2024
$2.4M
4,493 prescriptions
Company payments, 2025
$1,090
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Faheem A Abbasi was code 99213 (office e&m - established), 452 times for 340 patients. In total Faheem A Abbasi billed 1,652 services in 39 codes, and Medicare paid $100K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-11-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 452 | 340 | $56.46 | $26K |
| 99214 Office E&M - Established | Office | 154 | 115 | $86.56 | $13K |
| 99232 Hospital E&M - Subsequent | Facility | 121 | 66 | $58.09 | $7,029 |
| 99233 Hospital E&M - Subsequent | Facility | 115 | 64 | $85.54 | $9,837 |
| G0400 Home sleep test (hst) with type iv portable monitor, unattended; minimum of 3 channels | Office | 79 | 78 | $24.49 | $1,934 |
| G0399 Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 65 | 65 | $32.50 | $2,113 |
| 99291 Critical Care E&M | Facility | 65 | 37 | $144.36 | $9,383 |
| 94060 Pulmonary Function Testing | Office | 54 | 52 | $26.73 | $1,443 |
| 94729 Pulmonary Function Testing | Office | 53 | 51 | $36.92 | $1,957 |
| 95012 Pulmonary | Office | 53 | 50 | $11.33 | $600 |
| 99204 Office E&M - New | Office | 52 | 52 | $113.84 | $5,920 |
| 99203 Office E&M - New | Office | 51 | 51 | $72.83 | $3,714 |
| 94727 Pulmonary Function Testing | Office | 50 | 48 | $30.78 | $1,539 |
| 99222 Hospital E&M - Initial | Facility | 45 | 45 | $95.82 | $4,312 |
| 95811 Sleep Study | Office | 35 | 35 | $75.85 | $2,655 |
By year: 2022 $96K for 1,486 services; 2023 $101K for 1,598 services; 2024 $100K for 1,652 services.
Medicare prescription drug claims, 2024
In 2024, the drug Faheem A Abbasi prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 458 prescriptions and refills. In total Faheem A Abbasi wrote 4,493 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 458 | 551 | 132 | $12K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 450 | 614 | 88 | $385K |
| Prednisone Generic | 427 | 462 | 174 | $789 |
| Doxycycline Hyclate Generic | 273 | 279 | 126 | $1,330 |
| Breo Ellipta Fluticasone/Vilanterol | 171 | 226 | 32 | $90K |
| Montelukast Sodium Generic | 157 | 389 | 51 | $1,183 |
| Spiriva Respimat Tiotropium Bromide | 148 | 177 | 35 | $91K |
| Roflumilast Generic | 134 | 184 | 22 | $16K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 126 | 152 | 27 | $96K |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 126 | 171 | 24 | $80K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 122 | 164 | 30 | $75K |
| Zolpidem Tartrate Generic | 108 | 110 | 13 | $922 |
| Fluticasone Propionate Generic | 107 | 229 | 37 | $4,004 |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 104 | 104 | 16 | $1,821 |
| Clonazepam Generic | 94 | 102 | 15 | $589 |
Brand drugs: - claims; generic drugs: 2,275 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Faheem A Abbasi $1,090 ($1,090 in general payments such as food, travel and fees) from 21 companies. The largest payer was Abbvie Inc. with $160.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 6 | $160 |
| GlaxoSmithKline, LLC. GSK | 12 | $143 |
| Harmony Biosciences LLC HRMY | 3 | $125 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $82.42 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 3 | $81.24 |
| Axsome Therapeutics, Inc. AXSM | 2 | $48.61 |
| Verona Pharma, Inc. VRNA | 2 | $48.25 |
| Siemens Medical Solutions USA, Inc. SHL.DE | 1 | $42.81 |
| Merck Sharp & Dohme LLC MRK | 2 | $41.16 |
| Jazz Pharmaceuticals Inc. JAZZ | 1 | $39.69 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.